MOYA Bio Israeli Company
MOYA Bio is developing novel E1 inhibitors for solid and hematological malignancies.
Biopharma
Biotechnology
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Parent Companies/Investors
References
[1]
crunchbase.com
- https://www.crunchbase.com/organization/moya-bio
External links are provided for reference and verification purposes.